Great Point Partners Llc - Net Worth and Insider Trading

Great Point Partners Llc Net Worth

The estimated net worth of Great Point Partners Llc is at least $18 Million dollars as of 2024-12-25. Great Point Partners Llc is the 10% Owner of Adamas Pharmaceuticals Inc and owns about 2,216,351 shares of Adamas Pharmaceuticals Inc (ADMS) stock worth over $18 Million. Great Point Partners Llc is also the 10% Owner of InfuSystems Holdings Inc and owns about 0 shares of InfuSystems Holdings Inc (INFU) stock worth over $0. Details can be seen in Great Point Partners Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Great Point Partners Llc has not made any transactions after 2017-06-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Great Point Partners Llc

Great Point Partners Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Great Point Partners Llc owns 9 companies in total, including Foamix Pharmaceuticals Ltd (FOMX) , Adamas Pharmaceuticals Inc (ADMS) , and Connecture Inc (CNXR) among others .

Click here to see the complete history of Great Point Partners Llc’s form 4 insider trades.

Insider Ownership Summary of Great Point Partners Llc

Ticker	Comapny	Transaction Date	Type of Owner
FOMX	Foamix Pharmaceuticals Ltd	2018-09-13	other: Former 10% Owner
ADMS	Adamas Pharmaceuticals Inc	2017-06-21	10 percent owner
CNXR	Connecture Inc	2015-06-30	10 percent owner
		2013-12-13	10 percent owner
		2013-11-15	other: See Footnote 2
		2011-02-08	10 percent owner
		2009-08-26	director
		2006-03-21	10 percent owner
		2004-12-14	10 percent owner

Great Point Partners Llc Latest Holdings Summary

Great Point Partners Llc currently owns a total of 2 stocks. Among these stocks, Great Point Partners Llc owns 2,216,351 shares of Adamas Pharmaceuticals Inc (ADMS) as of June 21, 2017, with a value of $18 Million and a weighting of 100%. Great Point Partners Llc also owns 0 shares of InfuSystems Holdings Inc (INFU) as of February 8, 2011, with a value of $0 and a weighting of 0%.

Latest Holdings of Great Point Partners Llc

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ADMS	Adamas Pharmaceuticals Inc	2017-06-21	2,216,351	8.22	18,218,405
INFU	InfuSystems Holdings Inc	2011-02-08	0	8.21	0

Holding Weightings of Great Point Partners Llc

Great Point Partners Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Great Point Partners Llc has made a total of 0 transactions in Adamas Pharmaceuticals Inc (ADMS) over the past 5 years. The most-recent trade in Adamas Pharmaceuticals Inc is the sale of 380,000 shares on June 21, 2017, which brought Great Point Partners Llc around $6 Million.

According to the SEC Form 4 filings, Great Point Partners Llc has made a total of 0 transactions in InfuSystems Holdings Inc (INFU) over the past 5 years. The most-recent trade in InfuSystems Holdings Inc is the sale of 250,000 shares on February 8, 2011, which brought Great Point Partners Llc around $687,500.

Insider Trading History of Great Point Partners Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Great Point Partners Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Great Point Partners Llc Ownership Network

Ownership Network List of Great Point Partners Llc

No Data

Ownership Network Relation of Great Point Partners Llc

Great Point Partners Llc Owned Company Details

What does Foamix Pharmaceuticals Ltd do?

Who are the key executives at Foamix Pharmaceuticals Ltd?

Great Point Partners Llc is the other: Former 10% Owner of Foamix Pharmaceuticals Ltd. Other key executives at Foamix Pharmaceuticals Ltd include Chief Scientific Officer Iain Stuart , director & CEO David Domzalski , and CLO and General Counsel Mutya Harsch .

Foamix Pharmaceuticals Ltd (FOMX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Foamix Pharmaceuticals Ltd (FOMX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Foamix Pharmaceuticals Ltd (FOMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Foamix Pharmaceuticals Ltd (FOMX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Foamix Pharmaceuticals Ltd Insider Transactions

No Available Data

What does Adamas Pharmaceuticals Inc do?

Who are the key executives at Adamas Pharmaceuticals Inc?

Great Point Partners Llc is the 10 percent owner of Adamas Pharmaceuticals Inc. Other key executives at Adamas Pharmaceuticals Inc include Chief Commercial Officer Vijay Shreedhar , Chief Financial Officer Christopher B Prentiss , and director & 10 percent owner William W. Ericson .

Adamas Pharmaceuticals Inc (ADMS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Adamas Pharmaceuticals Inc (ADMS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adamas Pharmaceuticals Inc (ADMS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Adamas Pharmaceuticals Inc (ADMS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Adamas Pharmaceuticals Inc Insider Transactions

No Available Data

What does Connecture Inc do?

Who are the key executives at Connecture Inc?

Great Point Partners Llc is the 10 percent owner of Connecture Inc. Other key executives at Connecture Inc include 10 percent owner Francisco Partners Iv, L.p. , 10 percent owner Francisco Partners Iv-a, L.p. , and 10 percent owner Francisco Partners Gp Iv Management Ltd .

Connecture Inc (CNXR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Connecture Inc (CNXR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Connecture Inc (CNXR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Connecture Inc (CNXR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Connecture Inc Insider Transactions

No Available Data

What does Apyx Medical Corp do?

Who are the key executives at Apyx Medical Corp?

Great Point Partners Llc is the 10 percent owner of Apyx Medical Corp. Other key executives at Apyx Medical Corp include Executive Vice President Todd Hornsby , director & Chief Executive Officer Goodwin Charles D. Ii , and Chief Financial Officer Tara Semb .

Apyx Medical Corp (APYX) Insider Trades Summary

Over the past 18 months, Great Point Partners Llc made no insider transaction in Apyx Medical Corp (APYX). Other recent insider transactions involving Apyx Medical Corp (APYX) include a net sale of 30,000 shares made by Todd Hornsby , and a net purchase of 7,836 shares made by Matthew C Hill .

In summary, during the past 3 months, insiders sold 0 shares of Apyx Medical Corp (APYX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 30,000 shares of Apyx Medical Corp (APYX) were sold and 7,836 shares were bought by its insiders, resulting in a net sale of 22,164 shares.

Apyx Medical Corp (APYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Apyx Medical Corp Insider Transactions

No Available Data

What does WaferGen Bio-systems Inc do?

Who are the key executives at WaferGen Bio-systems Inc?

Great Point Partners Llc is the other: See Footnote 2 of WaferGen Bio-systems Inc. Other key executives at WaferGen Bio-systems Inc include 10 percent owner Awm Investment Company, Inc. , 10 percent owner Marxe Austin W & Greenhouse David M , and Interim CFO John M Harland .

WaferGen Bio-systems Inc (WGBS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of WaferGen Bio-systems Inc (WGBS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of WaferGen Bio-systems Inc (WGBS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

WaferGen Bio-systems Inc (WGBS)'s detailed insider trading history can be found in Insider Trading Tracker table.

WaferGen Bio-systems Inc Insider Transactions

No Available Data

What does InfuSystems Holdings Inc do?

Who are the key executives at InfuSystems Holdings Inc?

Great Point Partners Llc is the 10 percent owner of InfuSystems Holdings Inc. Other key executives at InfuSystems Holdings Inc include Executive Vice President Richard Dilorio , Executive VP and CIO Addam Chupa , and EVP-Chief HR Officer Jerod Funke .

InfuSystems Holdings Inc (INFU) Insider Trades Summary

Over the past 18 months, Great Point Partners Llc made no insider transaction in InfuSystems Holdings Inc (INFU). Other recent insider transactions involving InfuSystems Holdings Inc (INFU) include a net sale of 145,416 shares made by R. Rimmy Malhotra , a net sale of 40,000 shares made by Richard Dilorio , and a net purchase of 5,000 shares made by Paul Andrew Gendron .

In summary, during the past 3 months, insiders sold 40,000 shares of InfuSystems Holdings Inc (INFU) in total and bought 0 shares, with a net sale of 40,000 shares. During the past 18 months, 185,416 shares of InfuSystems Holdings Inc (INFU) were sold and 22,300 shares were bought by its insiders, resulting in a net sale of 163,116 shares.

InfuSystems Holdings Inc (INFU)'s detailed insider trading history can be found in Insider Trading Tracker table.

InfuSystems Holdings Inc Insider Transactions

No Available Data

What does Albireo Pharma Inc do?

Who are the key executives at Albireo Pharma Inc?

Great Point Partners Llc is the director of Albireo Pharma Inc. Other key executives at Albireo Pharma Inc include director & President and CEO Cooper Ronald Harold Wilfred , Chief Human Resources Officer Michelle Graham , and CFO and Treasurer Harford Simon N.r. .

Albireo Pharma Inc (ALBO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Albireo Pharma Inc (ALBO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Albireo Pharma Inc (ALBO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Albireo Pharma Inc (ALBO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Albireo Pharma Inc Insider Transactions

No Available Data

What does AMAG Pharmaceuticals Inc do?

Who are the key executives at AMAG Pharmaceuticals Inc?

Great Point Partners Llc is the 10 percent owner of AMAG Pharmaceuticals Inc. Other key executives at AMAG Pharmaceuticals Inc include 10 percent owner Camber Capital Management Lp , Chief Operating Officer Anthony Casciano , and Interim CFO Brian Piekos .

AMAG Pharmaceuticals Inc (AMAG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AMAG Pharmaceuticals Inc (AMAG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AMAG Pharmaceuticals Inc (AMAG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AMAG Pharmaceuticals Inc (AMAG)'s detailed insider trading history can be found in Insider Trading Tracker table.

AMAG Pharmaceuticals Inc Insider Transactions

No Available Data

What does Navidea Biopharmaceuticals Inc do?

Who are the key executives at Navidea Biopharmaceuticals Inc?

Great Point Partners Llc is the 10 percent owner of Navidea Biopharmaceuticals Inc. Other key executives at Navidea Biopharmaceuticals Inc include Chief Financial Officer Craig Dais , director & 10 percent owner Scott John K Jr. , and Chief Regulatory Officer Michel Mikhail .

Navidea Biopharmaceuticals Inc (NAVB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Navidea Biopharmaceuticals Inc (NAVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Navidea Biopharmaceuticals Inc (NAVB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Navidea Biopharmaceuticals Inc (NAVB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Navidea Biopharmaceuticals Inc Insider Transactions

No Available Data

Great Point Partners Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Great Point Partners Llc. You might contact Great Point Partners Llc via mailing address: 165 Mason Street, 3rd Floor, Greenwich Ct 06830.

Discussions on Great Point Partners Llc

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.